STOCKHOLDERS EQUITY (Table)

9 Months Ended

Jun. 30, 2022

STOCKHOLDERS EQUITY

Schedule options, stock bonuses and compensation granted by the company

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued		Remaining Options/Shares Under Plans
Incentive Stock Option Plans		138,400		75,329		N/A		213
Non-Qualified Stock Option Plans		13,787,200		12,909,350		N/A		455,508
Stock Bonus Plans		783,760		N/A		397,945		385,782
Stock Compensation Plans		634,000		N/A		153,195		462,395
Incentive Stock Bonus Plan		640,000		N/A		614,500		25,500

Schedule of stock option activity

	Nine Months Ended June 30,
	2022		2021
Options granted		1,975,250		2,603,500
Options exercised		6,500		126,954
Options forfeited		20,166		42,166
Options expired		13,614		9,374

	Three Months Ended June 30,
	2022		2021
Options granted		1,722,750		2,595,500
Options exercised		-		72,809
Options forfeited		-		-
Options expired		13,614		9,307

Schedule of Stock-Based Compensation Expense

	Nine months Ended June 30,
	2022		2021
Employees	$	9,102,774	$	10,090,410
Non-employees	$	603,147	$	955,900

	Three months Ended June 30,
	2022		2021
Employees	$	2,447,772	$	3,511,359
Non-employees	$	200,877	$	403,236

Schedule of Warrants and Non-Employee Options

Warrant/Options	Issue Date	Underlying Shares		Exercise Price		Expiration Date	Reference
Series N	8/18/2008		85,339	$	3.00	8/18/2024		2
Series UU	6/11/2018		93,603	$	2.80	6/30/2024		2
Series X	1/13/2016		120,000	$	9.25	7/13/2024		2
Series Y	2/15/2016		26,000	$	12.00	8/15/2024		2
Series MM	6/22/2017		333,432	$	1.86	6/22/2024		2
Series NN	7/24/2017		200,087	$	2.52	7/24/2024		2
Series RR	10/30/2017		251,761	$	1.65	10/30/2022	*
Series SS	12/19/2017		200,000	$	2.09	12/18/2022	*
Series TT	2/5/2018		600	$	2.24	2/5/2023	*
Consultants	7/28/2017 – 11/18/2020		15,000	$2.18 -$11.61		11/17/2022 - 7/27/2027	*

Schedule of fair value of the warrant liabilities

	June 30, 2022		September 30, 2021
Series Z warrants	$	-	$	64,787
Series AA warrants		-		276,035
Series CC warrants		-		94,961
Series HH warrants		-		1,597
Total warrant liabilities	$	-	$	437,380

Schedule of gains (losses) on the warrant liabilities

	2022		2021
Series W warrants	$	-	$	73,570
Series Z warrants		64,787		(113,094	)
Series ZZ warrants		-		(98,692	)
Series AA warrants		276,035		(306,606	)
Series BB warrants		-		48,477
Series CC warrants		24,372		(596,001	)
Series HH warrants		1,597		784
Net gain (loss) on warrant liabilities	$	366,791	$	(991,562	)

	2022		2021
Series Z warrants	$	-	$	583,404
Series ZZ warrants		-		(87,162	)
Series AA warrants		-		355,215
Series BB warrants		-		64,678
Series CC warrants		-		199,256
Series HH warrants		-		1,228
Net gain loss on warrant liabilities	$	-	$	1,116,619

Schedule of warrants recorded as liabilities

	Nine Months Ended June 30, 2021						Three Months Ended June 30, 2021
Warrants	Warrants Exercised		Exercise Price		Proceeds		Warrants Exercised		Exercise Price		Proceeds
Series Z		79,200	$	13.75	$	1,089,000		-		-	$	-
Series ZZ		20,000	$	13.75		275,000		19,200	$	13.75		264,000
Series AA		100,000	$	13.75		1,375,000		-		-		-
Series CC		107,298	$	5.00		536,490		5,000	$	5.00		25,000
		306,498			$	3,275,490		24,200			$	289,000

Schedule of warrants recorded as equity

	Nine Months Ended June 30, 2021						Three Months Ended June 30, 2021
Warrants	Warrants Exercised		Exercise Price		Proceeds		Warrants Exercised		Exercise Price		Proceeds
Series MM		464,201	$	1.86	$	863,414		147,929	$	1.86	$	275,148
Series NN		131,004	$	2.52		330,130		109,170	$	2.52		275,108
Series RR		165,888	$	1.65		273,715		95,799	$	1.65		158,068
Series SS		105,264	$	2.09		220,002		-	$	2.09		-
Series TT		270,696	$	2.24		606,359		60,214	$	2.24		134,879
		1,137,053			$	2,293,620		413,112			$	843,204